Guizhou Xinbang Pharmaceutical Co., Ltd.
SZSE:002390.SZ
4.56 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,032.262 | 6,460.841 | 6,350.026 | 6,471.866 | 5,845.622 | 6,655.064 | 6,580.279 | 6,002.471 | 5,157.032 | 4,179.756 | 2,476.183 | 569.488 | 447.572 | 361.865 | 318.628 | 336.686 | 274.743 | 217.754 | 173.328 |
| Cost of Revenue
| 4,996.368 | 5,232.265 | 5,133.065 | 5,119.371 | 4,593.544 | 5,190.549 | 5,146.748 | 4,745.862 | 4,048.841 | 3,318.622 | 1,837.85 | 213.936 | 166.983 | 128.706 | 111.226 | 103.404 | 85.388 | 76.635 | 60.738 |
| Gross Profit
| 1,035.895 | 1,228.576 | 1,216.96 | 1,352.496 | 1,252.078 | 1,464.515 | 1,433.531 | 1,256.609 | 1,108.19 | 861.135 | 638.333 | 355.552 | 280.59 | 233.159 | 207.402 | 233.282 | 189.355 | 141.118 | 112.59 |
| Gross Profit Ratio
| 0.172 | 0.19 | 0.192 | 0.209 | 0.214 | 0.22 | 0.218 | 0.209 | 0.215 | 0.206 | 0.258 | 0.624 | 0.627 | 0.644 | 0.651 | 0.693 | 0.689 | 0.648 | 0.65 |
| Reseach & Development Expenses
| 4.587 | 4.673 | 1.207 | 1.938 | 10.563 | 36.578 | 36.692 | 30.175 | 25.393 | 6.944 | 5.009 | 7.301 | 6.029 | 2.785 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 95.026 | 118.548 | 149.917 | 127.188 | 124.15 | 149.476 | 156.709 | 103.888 | 83.541 | 77.287 | 36.76 | 32.424 | 20.437 | 16.127 | 34.608 | 27.022 | 23.907 | 15.528 | 14.155 |
| Selling & Marketing Expenses
| 238.333 | 275.614 | 393.368 | 360.194 | 399.102 | 432.25 | 424.236 | 366.863 | 384.148 | 307.806 | 272.043 | 248.514 | 194.27 | 156.779 | 130.514 | 140.235 | 120.847 | 85.871 | 69.745 |
| SG&A
| 333.359 | 394.161 | 543.285 | 487.381 | 523.252 | 581.726 | 580.945 | 470.751 | 467.689 | 385.093 | 308.803 | 280.938 | 214.707 | 172.905 | 165.122 | 167.257 | 144.755 | 101.399 | 83.9 |
| Other Expenses
| 443.102 | 444.709 | 291.956 | 297.829 | 268.306 | 325.425 | -16.046 | -3.284 | 84.536 | 44.06 | 24.207 | 10.294 | 11.553 | -3.422 | 4.22 | 0.935 | 5.693 | 6.265 | 0.316 |
| Operating Expenses
| 781.047 | 843.543 | 836.448 | 787.148 | 802.121 | 943.729 | 929.11 | 730.392 | 712.217 | 555.444 | 397.46 | 307.76 | 232.437 | 190.466 | 168.962 | 170.942 | 147.556 | 103.636 | 85.755 |
| Operating Income
| 254.847 | 385.033 | 427.818 | 451.51 | 429.906 | 526.567 | -1,195.362 | 422.416 | 231.184 | 184.412 | 175.051 | 37.487 | 45.87 | 48.595 | 38.918 | 53.255 | 32.919 | 28.075 | 21.156 |
| Operating Income Ratio
| 0.042 | 0.06 | 0.067 | 0.07 | 0.074 | 0.079 | -0.182 | 0.07 | 0.045 | 0.044 | 0.071 | 0.066 | 0.102 | 0.134 | 0.122 | 0.158 | 0.12 | 0.129 | 0.122 |
| Total Other Income Expenses Net
| -69.346 | 10.988 | -2.929 | -30.385 | -162.45 | -195.09 | -16.046 | -3.284 | 84.536 | 43.787 | 23.985 | 10.294 | 11.493 | 4.933 | 5.227 | -5.261 | -3.376 | -2.749 | 0.299 |
| Income Before Tax
| 185.501 | 396.022 | 313.394 | 421.125 | 267.456 | 331.477 | -1,211.408 | 419.132 | 312.012 | 228.2 | 199.036 | 47.782 | 57.363 | 53.528 | 44.145 | 54.19 | 38.584 | 34.414 | 21.455 |
| Income Before Tax Ratio
| 0.031 | 0.061 | 0.049 | 0.065 | 0.046 | 0.05 | -0.184 | 0.07 | 0.061 | 0.055 | 0.08 | 0.084 | 0.128 | 0.148 | 0.139 | 0.161 | 0.14 | 0.158 | 0.124 |
| Income Tax Expense
| 29.811 | 42.249 | 44.977 | 47.17 | 46.881 | 67.756 | 71.775 | 87.645 | 69.308 | 59.79 | 45.179 | 8.106 | 9.8 | 7.652 | 6.562 | 7.773 | 4.97 | 4.503 | 4.641 |
| Net Income
| 101.382 | 287.233 | 224.374 | 373.955 | 173.521 | 236.302 | -1,296.605 | 319.384 | 246.013 | 174.379 | 144.77 | 40.237 | 47.829 | 46.079 | 37.757 | 46.416 | 33.614 | 29.911 | 17.451 |
| Net Income Ratio
| 0.017 | 0.044 | 0.035 | 0.058 | 0.03 | 0.036 | -0.197 | 0.053 | 0.048 | 0.042 | 0.058 | 0.071 | 0.107 | 0.127 | 0.119 | 0.138 | 0.122 | 0.137 | 0.101 |
| EPS
| 0.053 | 0.15 | 0.12 | 0.21 | 0.11 | 0.15 | -0.8 | 0.19 | 0.15 | 0.14 | 0.13 | 0.048 | 0.056 | 0.054 | 0.048 | 0.072 | 0.052 | 0.046 | 0.027 |
| EPS Diluted
| 0.053 | 0.15 | 0.12 | 0.21 | 0.11 | 0.15 | -0.8 | 0.19 | 0.15 | 0.14 | 0.13 | 0.048 | 0.056 | 0.054 | 0.048 | 0.072 | 0.052 | 0.046 | 0.027 |
| EBITDA
| 443.358 | 692.333 | 608.727 | 768.647 | 632.492 | 734.629 | -825.852 | 699.483 | 471.421 | 480.012 | 323.24 | 84.317 | 76.702 | 66.148 | 55.044 | 61.802 | 48.744 | 44.518 | 28.352 |
| EBITDA Ratio
| 0.073 | 0.107 | 0.096 | 0.119 | 0.108 | 0.11 | -0.126 | 0.117 | 0.091 | 0.115 | 0.131 | 0.148 | 0.171 | 0.183 | 0.173 | 0.184 | 0.177 | 0.204 | 0.164 |